Quinotrierixin inhibits proliferation of human retinal pigment epithelial cells

Molecular Vision

Volumn 19, Issue , 2013, Pages 39-46

  Chen, Chen ^a,b,c   Wang, Joshua J ^b,c   Li, Jingming ^b,c   Yu, Qiang ^a   Zhang, Sarah X ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CCAAT ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; MESSENGER RNA; PROTEIN INHIBITOR; PROTEIN KINASE R; QUINOTRIERIXIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NICK END LABELING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RNA SPLICING; VITREORETINOPATHY;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA-BINDING PROTEINS; EIF-2 KINASE; ENDOPLASMIC RETICULUM STRESS; EPITHELIAL CELLS; HUMANS; RETINAL PIGMENT EPITHELIUM; RIFABUTIN; RNA SPLICING; THAPSIGARGIN; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84872840161     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 1992; 110:770-9. [PMID: 1596224].
2. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol 1985; 100:188-93. [PMID: 4014372].
3. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995; 79:953-60. [PMID: 7488586].
4. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998; 17:77-98. [PMID: 9537796].
5. Cheng HC, Ho TC, Chen SL, Lai HY, Hong KF, Tsao YP. Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells. Mol Vis 2008; 14:95-104. [PMID: 18253093].
6. Nassar K, Luke J, Luke M, Kamal M, Abd El-Nabi E, Soliman M, Rohrbach M, Grisanti S. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol 2011; 249:1649-60. [PMID: 21735240].
7. Kita T, Hata Y, Kano K, Miura M, Nakao S, Noda Y, Shimokawa H, Ishibashi T. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 2007; 56:231-8. [PMID: 17192487].
8. Kawahara S, Hata Y, Kita T, Arita R, Miura M, Nakao S, Mochizuki Y, Enaida H, Kagimoto T, Goto Y, Hafezi-Moghadam A, Ishibashi T. Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. Diabetes 2008; 57:2784-93. [PMID: 18599521].
9. Sparrow JR, Hicks D, Hamel CP. The retinal pigment epithelium in health and disease. Curr Mol Med 2010; 10:802-23. [PMID: 21091424].
10. Leiderman YI, Miller JW. Proliferative vitreoretinopathy: pathobiology and therapeutic targets. Semin Ophthalmol 2009; 24:62-9. [PMID: 19373688].
11. Doyle JW, Dowgiert RK, Buzney SM. Factors modulating the effect of retinoids on cultured retinal pigment epithelial cell proliferation. Curr Eye Res 1992; 11:753-65. [PMID: 1385038].
12. Kon CH, Occleston NL, Foss A, Sheridan C, Aylward GW, Khaw PT. Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy. Br J Ophthalmol 1998; 82:554-60. [PMID: 9713065].
13. Handa JT, Murad S, Jaffe GJ. Inhibition of cultured human RPE cell proliferation and lysyl hydroxylase activity by hydroxy derivatives of minoxidil. Invest Ophthalmol Vis Sci 1994; 35:463-9. [PMID: 8112995].
14. Sakamoto T, Hinton DR, Kimura H, Spee C, Gopalakrishna R, Ryan SJ. Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1996; 234:186-92. [PMID: 8720718].
15. Hermel M, Heckelen A, Kirchhof B, Schrage NF. Inhibitory effect of ascorbic acid on human retinal pigment epithelial cell proliferation compared to cytostatic drugs-influence of histamine. Inflamm Res 2001; 50:Suppl 2S93-5. [PMID: 11411620].
16. Kawamura T, Tashiro E, Shindo K, Imoto M. SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhibitors of ER stress-induced XBP1 activation. J Antibiot (Tokyo) 2008; 61:312-7. [PMID: 18653997].
17. Kawamura T, Tashiro E, Yamamoto K, Shindo K, Imoto M. SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhibitors of ER stress-induced XBP1 activation. J Antibiot (Tokyo) 2008; 61:303-11. [PMID: 18653996].
18. Yamamoto K, Tashiro E, Imoto M. Quinotrierixin inhibited ER stress-induced XBP1 mRNA splicing through inhibition of protein synthesis. Biosci Biotechnol Biochem 2011; 75:284-8. [PMID: 21307594].
19. Wang M, Wang JJ, Li J, Park K, Qian X, Ma JX, Zhang SX. Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. Am J Physiol Endocrinol Metab 2009; 297:E1378-87. [PMID: 19808909].
20. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001; 107:881-91. [PMID: 11779464].
21. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007; 318:944-9. [PMID: 17991856].
22. Li J, Wang JJ, Zhang SX. Preconditioning with endoplasmic reticulum stress mitigates retinal endothelial inflammation via activation of X-box binding protein 1. J Biol Chem 2011; 286:4912-21. [PMID: 21138840].
23. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999; 13:1211-33. [PMID: 10346810].
24. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 23:7448-59. [PMID: 14559994].
25. Gomez BP, Riggins RB, Shajahan AN, Klimach U, Wang A, Crawford AC, Zhu Y, Zwart A, Wang M, Clarke R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J 2007; 21:4013-27. [PMID: 17660348].
26. Thorpe JA, Schwarze SR. IRE1alpha controls cyclin A1 expression and promotes cell proliferation through XBP-1. Cell Stress Chaperones 2010; 15:497-508. [PMID: 20013084].
27. Zhong Y, Li J, Wang J, Chen C, Tran JA, Lee A-H, Mandal MN, Le Y-Z, Zhang SX. Deficiency of X-box binding protein 1 induces oxidative damage of the RPE: implications in age-related retinal degeneration. PLoS ONE 2012; 7:e38616-[PMID: 22715395].